All conference submissions

Radiopharmaceutical therapy (RPT) plays an important role in the management of oncology patients, particularly those with thyroid cancer, prostate cancer, and neuroendocrine tumor. The use of radionuclide therapy has expanded rap...

The purpose of this research is to develop a method for extracting and processing PET/CT and planning CT (pCT) with dose distribution. This method aims to address the challenge of co-registering data from different imaging modali...

In the process to calculate the delivered Y-90 (Yttrium-90) dosage, there is measurement uncertainty associated with each step. All these uncertainties can be calculated with the knowledge of the dose calibrator and survey meter...

Post-therapy quantitative imaging is essential for dosimetry-guided precision cancer treatment in theranostics. Although SPECT is the typical choice for post-therapy quantification, its routine clinical use is constrained by scan...

To determine the feasibility of using a high temporal resolution electronic dosimeter (NetDose+, manufactured by ThermoScientific) for patient-specific pharmacokinetic data collection and analysis for the immediate post-administr...

Dose–volume histograms (DVHs) are widely used in external beam radiation therapy, but their applicability to Y-90 transarterial radioembolization (TARE) remains uncertain. In Y-90 TARE, absorbed dose maps are derived from post-th...

Resin Yttrium-90 (Y-90) selective internal radiation therapy (SIRT) is a radioembolization procedure that uses Y-90 microspheres to treat metastatic liver cancer. In the procedure, liver volume and tumor volume are needed for Y-9...

To develop a Web-Based Theranostic Workflow Management Tool (TWMT) to efficiently manage Theranostic program in the department of radiation oncology (RadOnc).

Occupational exposure during Lutetium-177 (Lu-177) radiopharmaceutical therapy depends on administration technique, shielding configuration, and staff proximity—temporal and spatial. This study quantified extremity and whole-body...

The proposed multimodal segmentation framework, named EPIDSeg-Net, comprises an encoder, a multi-scale feature layer, and a decoder. The encoder utilizes a dual-branch architecture: a CNN branch for extracting local texture featu...

A system matrix (SM) was designed to incorporate the distance dependent blurring in MLEM reconstruction for SPECT.

Glioblastoma (GBM) remains a lethal brain cancer with a devastating median survival of about 15 months with the current standard of treatment involving surgery, radiation therapy, and chemotherapy utilizing temozolomide (TMZ). Ra...

A modified lung shunt fraction (LSF) based on conventional 2D planar imaging data was proposed. That modified LSF can reduce the 2D overestimation errors and get closer results with 3D SPECT images.

To quantify uncertainty in SPECT sensitivity factor used for Lu-177 radiopharmaceutical dosimetry.

Tumor-to-normal ratio (TNR) derived from pretreatment Tc-99m MAA SPECT/CT is widely used as a surrogate marker of perfusion in yttrium-90 (⁹⁰Y) radioembolization for patients with hepatocellular carcinoma (HCC). Delivered activit...

Radiopharmaceuticals, Theranostics, and Nuclear Medicine

Radiopharmaceuticals, Theranostics, and Nuclear Medicine

Radiopharmaceuticals, Theranostics, and Nuclear Medicine

Radiopharmaceuticals, Theranostics, and Nuclear Medicine

Radiopharmaceuticals, Theranostics, and Nuclear Medicine

Radiopharmaceuticals, Theranostics, and Nuclear Medicine

Radiopharmaceuticals, Theranostics, and Nuclear Medicine

Radiopharmaceuticals, Theranostics, and Nuclear Medicine

Radiopharmaceuticals, Theranostics, and Nuclear Medicine